Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
SDF1-3'A was also associated with decreased risk for AIDS, but its effect was only evident when CCR2-64I was present as well.
|
21739027 |
2011 |
Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
A longitudinal study was conducted to evaluate the association of the SDF1 polymorphism and the progression of HIV-1 infection in 161 asymptomatic patients infected with HIV-1 (ASYMPT) and 617 patients with AIDS (SYMPT) from Londrina and the surrounding region, southern Brazil.
|
16964435 |
2006 |
Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Evaluating spatial distribution of the genetic susceptibility of HIV (AIDS) to CCR2-64I and SDF1-3'A alleles, should focus on the frequencies of combined genotypes of CCR2 and SDF1 based on the two-locus genotypes of each individual rather than the frequencies of CCR2-64I and SDF1-3'A alleles.
|
16274106 |
2005 |
Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
LHGDN |
Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study.
|
16177829 |
2005 |
Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
CCR2-64I and CXCL12 3'A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapy.
|
16286054 |
2005 |
Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
On the basis of a regression tree approach using a Cox proportional hazards model for times to clinical AIDS, the combinations of genes associated with the greatest protection, relative to the lack of a protective genotype, consisted of: 1) C-C chemokine receptor 5 (CCR5)-Delta 32 and C-C chemokine receptor 2 (CCR2)-64I (relative hazard = 0.44); 2) interleukin 10 (IL10)-+/+ in combination with CCR5-Delta 32 or CCR2-64I (relative hazard = 0.45); and 3) IL10-+/+ in combination with stromal-derived factor (SDF1)-3 'A and CCR5 promoter P1/approximately P1 (relative hazard = 0.37).
|
14742283 |
2004 |
Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Mutations in CCR2 (CCR2-64I) and stromal-derived factor SDF1 (SDF1-3'A), the primary ligand for CXCR4, exhibited a protective effect against the onset of acquired immune deficiency syndrome (AIDS).
|
12436194 |
2002 |
Acquired Immunodeficiency Syndrome
|
0.100 |
Biomarker
|
group |
LHGDN |
Expression of stromal cell-derived factor 1alpha protein in HIV encephalitis.
|
12044982 |
2002 |
Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The significance of higher frequencies of CCR2-641 and SDF1-3' A alleles (0.20023 and 0.2791) in the Han population remains to be clarified in HIV-1-positive carriers and AIDS patients.
|
11729511 |
2001 |
Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Mutations at CCR5 (CCR5-delta2), CCR2 (CCR2-641), and stromal-derived factor SDF1 (SDF1-3'A), a primary ligand for CXCR4, are known to have protective effects against HIV-1 infection and the onset of AIDS symptoms.
|
11175286 |
2000 |
Acquired Immunodeficiency Syndrome
|
0.100 |
Biomarker
|
group |
BEFREE |
Chemokine receptor CCR2 and stromal-derived factor (SDF-1) are involved in HIV infection and AIDS symptom onset.
|
10486323 |
1999 |
Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The recessive protective effect of SDF1-3'A was increasingly pronounced in individuals infected with HIV-1 for longer periods, was twice as strong as the dominant genetic restriction of AIDS conferred by CCR5 and CCR2 chemokine receptor variants in these populations, and was complementary with these mutations in delaying the onset of AIDS.
|
9430590 |
1998 |
Acquired Immunodeficiency Syndrome
|
0.100 |
Biomarker
|
group |
BEFREE |
Composite genetic epidemiologic analyses of genotypes bearing CCR5P1, CCR5-Delta32, CCR2-64I, and SDF1-3'A affirmed distinct regulatory influences for each gene on AIDS progression.
|
9836644 |
1998 |